This acquisition signifies Radformation’s commitment to driving innovation and expanding its AI-driven capabilities in cancer care.

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired privately-held Limbus AI, a leading global provider of automated contouring software for radiation therapy. This acquisition signifies Radformation’s commitment to driving innovation and expanding its AI-driven capabilities in cancer care.

“Our mission has always been to improve the radiation therapy process, focusing on efficiency, quality, and safety in patient care,” said Kurt Sysock, CEO of Radformation. “With Limbus' innovative technology and expertise now part of our team, we are even more equipped to advance the frontier of innovative software solutions in radiation therapy.”

This merger aims to harness the collective strengths of both companies' platforms by integrating the superior features of each system, offering the most advanced AI-driven contouring solution available today. Beyond improving contouring, this effort is expected to spark further innovation, leading to new developments and improvements in radiation therapy.

“We share a similar vision to bring innovative software to patient care,” said Karl Otto, CEO of Limbus AI. “Both companies have very talented and hard working teams that, when combined, will be able to achieve great things together.”

Radformation’s acquisition of Limbus AI unites two leaders in clinical treatment planning, combining Radformation’s extensive global presence and robust product utilization – spanning 8 products used in over 1,600 clinics in 28 countries – with Limbus’ significant impact on 500,000 patients across 400 centers worldwide. This alliance will accelerate innovation, expand reach, and enhance patient outcomes worldwide, marking a new era in healthcare technology.

For more information: www.radformation.com


Related Content

News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
News | Lung Imaging

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global ...

Time June 11, 2025
arrow
News | Radiology Imaging

June 10, 2025 — CIVIE has announced the official launch of RadPod, an AI-driven, on-demand radiology platform designed ...

Time June 10, 2025
arrow
News | Ultrasound Imaging

June 4, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time June 09, 2025
arrow
News | Mammography

June 9, 2025 — A new independent, peer-reviewed study published in the journal Clinical Breast Cancer reinforces the ...

Time June 09, 2025
arrow
News | Imaging Software Development

June 05, 2025 — Nano-X Imaging Ltd. has announced that its deep-learning medical imaging analytics subsidiary, Nanox AI ...

Time June 05, 2025
arrow
News | Prostate Cancer

June 5, 2025 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time June 05, 2025
arrow
News | Ultrasound Imaging

June 3, 2025 — In a collaborative study between the Departments of Radiology at the Children’s Hospital of Philadelphia ...

Time June 04, 2025
arrow
Subscribe Now